You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
英科醫療(300677.SZ):擬以1億美元投資Warburg Pincus Global Growth 14, L.P.
格隆匯 02-11 17:05

格隆匯2月11日丨英科醫療(300677.SZ)公佈,為進一步優化投資結構,提升投資價值,公司全資子公司英科醫療(新加坡)投資有限公司(Intco MedicalInvestment Singapore PTE.LTD.“新加坡公司”)Warburg PincusGlobal Growth 14 GP, L.P. (“華平資本”Warburg Pincus Global)簽署《認購協議》,以自有資金投資Warburg Pincus Global Growth 14, L.P. (合夥企業“基金”)。合夥企業的目標認繳出資總額為160億美元其中,新加坡公司將作為該合夥的有限合夥人(LP)認繳出資1億美元

合夥企業投資方向商業服務、金融服務、醫療健康、工業、科技、房地產和能源領域的成長資本、早期成長平台、公司收購和資本重組投資等。

公司此次投資合夥企業,可以結合合夥企業在全球商業服務、醫療健康、工業、科技等行業的經驗和資源,賦能公司未來的海內外戰略併購工作,並拓展公司的投資渠道,獲取投資收益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account